AR and prostate carcinoma: When the hormonal ligands testosterone and 5‐dihydrotestosterone bind to AR, it dissociates from accessory proteins and transfers to the nucleus, triggering the expression of genes involved in cell proliferation and evasion of apoptosis, thereby boosting prostate cancer development [37].